Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Cash & Equivalents: 2009-2012

Historic Cash & Equivalents for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $20.8 million.

  • Lexicon Pharmaceuticals' Cash & Equivalents fell 31.98% to $20.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $20.8 million, marking a year-over-year decrease of 31.98%. This contributed to the annual value of $186.3 million for FY2011, which is 294.66% up from last year.
  • According to the latest figures from Q3 2012, Lexicon Pharmaceuticals' Cash & Equivalents is $20.8 million, which was down 38.54% from $33.8 million recorded in Q2 2012.
  • Lexicon Pharmaceuticals' 5-year Cash & Equivalents high stood at $260.1 million for Q1 2010, and its period low was $17.0 million during Q1 2009.
  • For the 3-year period, Lexicon Pharmaceuticals' Cash & Equivalents averaged around $100.7 million, with its median value being $33.8 million (2012).
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Cash & Equivalents skyrocketed by 1,434.40% in 2010, and later slumped by 92.27% in 2011.
  • Over the past 4 years, Lexicon Pharmaceuticals' Cash & Equivalents (Quarterly) stood at $100.6 million in 2009, then crashed by 53.05% to $47.2 million in 2010, then soared by 294.66% to $186.3 million in 2011, then crashed by 31.98% to $20.8 million in 2012.
  • Its Cash & Equivalents stands at $20.8 million for Q3 2012, versus $33.8 million for Q2 2012 and $29.0 million for Q1 2012.